Evidence presented to the inquiry held that while most doctors took the view that not discussing the risks associated with blood products with patients would not result in deterring patients from using the various treatments anyway. However, Professors Farsides and Kerridge on the medical experts panel to the inquiry disagreed, stating until one has disclosed all the risks to a patient, then one cannot assume patients are making a fully informed decision.